Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Motivational Enhancement for Spanish Speaking Individuals - 1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00078169
Recruitment Status : Completed
First Posted : February 23, 2004
Last Update Posted : January 12, 2017
Sponsor:
Collaborator:
University of Miami
Information provided by:
National Institute on Drug Abuse (NIDA)

Tracking Information
First Submitted Date  ICMJE February 19, 2004
First Posted Date  ICMJE February 23, 2004
Last Update Posted Date January 12, 2017
Study Start Date  ICMJE November 2003
Actual Primary Completion Date October 2005   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: August 2, 2005)
Treatment retention, drug and alcohol abstinence
Original Primary Outcome Measures  ICMJE Not Provided
Change History Complete list of historical versions of study NCT00078169 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Motivational Enhancement for Spanish Speaking Individuals - 1
Official Title  ICMJE Motivational Enhancement for Spanish Speaking Individuals
Brief Summary The purpose of this study is to compare a three-session Spanish version of Motivational Enhancement Therapy (MET) to standard treatment to see how well MET engages and retains Spanish-speaking clients in outpatient substance abuse treatment.
Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Phase 3
Study Design  ICMJE Primary Purpose: Treatment
Condition  ICMJE Substance-Related Disorders
Intervention  ICMJE Behavioral: Behavior Therapy
Study Arms  ICMJE Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Enrollment  ICMJE
 (submitted: October 11, 2005)
463
Original Enrollment  ICMJE
 (submitted: June 23, 2005)
461
Actual Study Completion Date  ICMJE October 2005
Actual Primary Completion Date October 2005   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

All subjects included unless medical/psychiatrically unstable

Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 99 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT00078169
Other Study ID Numbers  ICMJE NIDA-CTN-0021-1
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Kathleen Carroll, Ph.D., Yale University School of Medicine
Study Sponsor  ICMJE Yale University
Collaborators  ICMJE University of Miami
Investigators  ICMJE
Principal Investigator: Kathleen Carroll, Ph.D. Yale University
PRS Account National Institute on Drug Abuse (NIDA)
Verification Date October 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP